Carmat announces the completion of its capital increase for a total gross amount (including issue premium) of 10.3 million euros, in which two reference shareholders participated for 5.5 million.

On September 28, Carmat's Chief Executive Officer decided to issue 6,414,516 new ordinary shares at a price of 1.60 euro. Settlement-delivery and listing on Euronext Growth Paris are scheduled for October 2.

The net proceeds of the €9.4 million operation will enable the designer of the Aeson artificial heart to extend its financial horizon to early 2025. After the offer, its 12-month financing requirement is approximately 36 million.

Copyright (c) 2024 CercleFinance.com. All rights reserved.